10-89339671-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001549.6(IFIT3):āc.1016T>Cā(p.Leu339Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,614,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001549.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFIT3 | NM_001549.6 | c.1016T>C | p.Leu339Pro | missense_variant | 2/2 | ENST00000371818.9 | NP_001540.2 | |
LOC101926887 | XR_946183.4 | n.80-1336A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFIT3 | ENST00000371818.9 | c.1016T>C | p.Leu339Pro | missense_variant | 2/2 | 1 | NM_001549.6 | ENSP00000360883 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152250Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 28AN: 251008Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135632
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461872Hom.: 0 Cov.: 33 AF XY: 0.0000440 AC XY: 32AN XY: 727240
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152368Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74512
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | The c.1016T>C (p.L339P) alteration is located in exon 2 (coding exon 2) of the IFIT3 gene. This alteration results from a T to C substitution at nucleotide position 1016, causing the leucine (L) at amino acid position 339 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at